摘要
目的:探讨减压病的发病机理及治疗方案。方法:将60例神经系统减压病的患者随机分为2组:A组28例接受氟桂利嗪和加压治疗,B组32例只接受加压治疗。另收集未进行加压治疗的神经系统减压病患者36例作为比较,其中病初使用扩血管药物的20例为C组,未使用扩血管药物的16例为D组。采用欧洲卒中量表(ESS),Barthel指数(BI)评价神经功能恢复状况。结果:扩血管治疗组ESS分数迅速增加,组间(A组与B组,C组与D组)差异有统计学意义。结论:血管痉挛可能是减压病的重要病因之一,因而扩血管治疗对神经系统减压病有效。
Objective： To investigate the pathogenic mechanism and treatment prescription of decompression sickness（DCS）. Methods：A total of 60 patients with DCS in nervous system were randomly divided into 2 groups. Group A （28 cases） received flunarizine administration with recompression therapy, while group B （32 cases） were given recompression treatment only. At the same time, dates of 36 patients with DCS in nervous system did not received recompression therapy were collected. 20 cases of them were treated with vasodilator therapy at initial stage （group C）, while the other 16 patients were not received any treatment （group D）. European Stroke Scale （ESS） and Barthel Index （BI） were used to evaluate the recovery of nervous functions. Results：The ESS score increased rapidly in vasodilator treatment group, and there were statistical significances in groups （group A compared with group B, group C compared with group D）. Conclusions： Angiospasm may he one of the important causes of DCS, so vasodilator therapy is effective to DCS in nervous system.
出处
《海军医学杂志》
2007年第2期103-105,共3页
Journal of Navy Medicine
关键词
减压病
扩血管治疗
加压治疗
decompression sickness
vasodilator treatment
recompression therapy
